---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-058687"
form_type: "8-K"
ticker: "ALXO"
cik: "0001810182"
company_name: "ALX ONCOLOGY HOLDINGS INC"
filed_at: "2025-04-25T23:59:59+00:00"
generated_at: "2026-05-23T05:59:45.536756+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# ALX Oncology receives Nasdaq bid price non-compliance notice; 180-day cure until Oct 20, 2025

## Summary
- Nasdaq notified ALXO on Apr 23, 2025 that its common stock failed to maintain $1.00 minimum bid price for 30 consecutive business days.
- Company has until Oct 20, 2025 to regain compliance by closing at or above $1.00 for at least ten consecutive business days.
- If not cured, ALXO may seek a second 180-day period by transferring to the Nasdaq Capital Market, subject to eligibility.
- Potential cure actions include a reverse stock split; failure to regain compliance could lead to delisting.
- ALXO intends to actively monitor bid price and assess options, but no assurance of regaining compliance.

## SEC filing metadata
- accession: 0000950170-25-058687
- form_type: 8-K
- ticker: ALXO
- cik: 0001810182
- company_name: ALX ONCOLOGY HOLDINGS INC
- filed_at: 2025-04-25T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1810182/000095017025058687/0000950170-25-058687-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1810182/000095017025058687/alxo-20250423.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-058687
- JSON: https://secwatch.observer/filing/0000950170-25-058687.json
- Plain text: https://secwatch.observer/filing/0000950170-25-058687.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.